Alio, Inc.

Industry
Medical Technology
Founded Year
2012
Headquarters
10901 W 120th Ave Suite 380, Broomfield, Colorado 80021, USA
Employee Count
51

Key People

Assessment

Team
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with diverse backgrounds in medical devices, wearable technology, and commercialization.

Alio's leadership includes individuals with proven track records in MedTech, enhancing the company's potential for innovation and market penetration.

Clinical Need
Aspect: Very Strong
Summary: Alio addresses a critical need for non-invasive, continuous monitoring in chronic disease management, particularly for dialysis patients.

By providing continuous, non-invasive monitoring, Alio's SmartPatch offers a substantial improvement over traditional methods, potentially reducing hospitalizations and improving patient outcomes.

Competition
Aspect: First mover
Summary: Alio is pioneering non-invasive potassium monitoring, with limited direct competition in this specific niche.

Alio's unique offering positions it ahead of competitors, allowing the company to establish market leadership and set industry standards.

Technical Challenge
Aspect: Very Complex
Summary: Developing accurate, non-invasive monitoring technology for multiple health metrics presents significant technical challenges.

The intricate nature of Alio's technology requires substantial R&D investment and expertise, potentially affecting time-to-market and scalability.

Patent
Aspect: Very Strong
Summary: Alio holds robust patents protecting its innovative non-invasive monitoring technology.

Comprehensive patents safeguard Alio's technology, deterring competitors and supporting long-term market dominance.

Financing
Aspect: Well-funded
Summary: Alio has secured over $50 million in funding, including an $18 million Series C round in December 2022.

The substantial capital raised enables Alio to advance its technology, expand operations, and navigate regulatory processes effectively.

Regulatory
Aspect: 510k/PMA
Summary: Alio has received FDA clearance for its SmartPatch, allowing for non-invasive monitoring of key health metrics.

FDA clearance validates the safety and efficacy of Alio's technology, enabling commercialization and building trust among healthcare providers and patients.

Opportunity Rollup

Odds of Success
2.9
Peak Market Share
3.45
Segment CAGR
3.6%
Market Segment
Patient Monitoring
Market Sub Segment
Remote Patient Monitoring
Year Post Launch Market Penetration (%)
1 0.17
2 0.52
3 1.21
4 2.42
5 3.45

Key Takeaway

Alio's innovative non-invasive monitoring technology addresses a critical need in chronic disease management, positioning the company for significant growth in the patient monitoring market.